Ranbaxy Laboratories is the largest pharmaceutical company in India and one of the top ten generic drug manufacturers worldwide. It was established in 1961 and went public in 1973. In 2005 the company had an yearly revenue of US $1178 Mln. Their biggest markets are the USA, Europe, Brazil, Russia, India and China.

Unlike most generic drug manufacturers, Ranbaxy has invested in research and development almost from the very beginning of the company. In 1994 the company opened it’s first R&D center on the outskirts of New Delhi, India. Ranbaxy plans to increase their R&D budget from 7% of the sales ( in 2004 ) to 10% of the sales by 2007, which is the largest R&D budget amongst Indian companies.